BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:With 128 TGF-B targeted therapies in the clinic and 68 in the 
 preclinical stage\, the TGF-B field is currently being rejuvenated by nov
 el approaches in immuno-oncology\, and cutting edge research in fibrosis\
 , autoimmune diseases\, and beyond.\n\nThe TGF-B Targeted Drug Developmen
 t Summit returns to San Francisco for the 4th year to deep dive into the 
 hottest topics in the field\, such as combination strategies being employ
 ed by Genentech and discovering new and predictive biomarkers from Corbus
  Pharmaceuticals. This meeting will support you in securing clinical succ
 ess with safe and efficacious TGF-B targeted therapies.\n\nWith a program
  consisting of TGF-B industry leaders such as Cue Biopharma\, Synthis\, a
 nd Pfizer\, this year promises to spotlight innovative ways biotech and l
 arge pharma companies are overcoming toxicity\, translation\, and proving
  clinical efficacy. Join us in October to celebrate the accomplishments o
 f the TGF-B field and anticipate the future towards clinically effective 
 and approved TGF-B targeted therapies.\n\nDate and Time: Tuesday\, 15 Oct
 ober 2024 at 09:00 to Thursday\, 17 October 2024 at 17:00\n
DTEND:20241017T170000
DTSTAMP:20260512T230905Z
DTSTART:20241015T090000
LOCATION:The Clift Royal Sonesta San Francisco\, 495 Geary Street\, San Fr
 ancisco\, California\, 94102\,
SEQUENCE:0
SUMMARY:With 128 TGF-B targeted therapies in the clinic and 68 in the prec
 linical stage\, the TGF-B field is currently being rejuvenated by novel a
 pproaches...
UID:0837ad5d-6002-460f-9054-eceed2eb394c
END:VEVENT
END:VCALENDAR